Roger Davy

Managing Director

Roger Davy is a seasoned professional with a passion for problem-solving and extensive experience gained in industry and consulting roles in the life sciences and microelectronics sectors.

Throughout his career, Roger has consistently demonstrated his ability to lead teams and deliver results. He has held positions at Applied Materials, AstraZeneca and USDM Life Sciences, most recently serving as Vice President of Consulting. In this role, he spearheaded customer initiatives in IT strategy, cybersecurity, business continuity, quality, compliance, and commercial readiness. Roger has also served as the acting Head of IT / CIO for three clinical-phase biopharma companies.

Roger’s expertise extends to regulatory compliance, particularly in areas such as SOX controls, 21 CFR Parts 11, 210, 211, and 820/ISO13485, GAMP 5, ISO27001, and all GxP domains. He is among the first to advise Life Science customers on compliance for GxP use cases of AI/ML and GMLP.

Roger’s career trajectory reflects a commitment to excellence and a passion for driving innovation in the life sciences industry. His diverse skill set, combined with his educational background and leadership experience, positions him as a valuable asset to any organization seeking to navigate the complexities of the ever-evolving technology and regulatory landscapes.

Roger has a strong educational foundation that complements his practical expertise. He earned his MBA from the University of Southern California in Los Angeles and his bachelor’s in chemical engineering from University of New South Wales in Sydney, Australia.

Areas of Focus

Technology, Quality and Regulatory Compliance across all GxP Domains
Digital transformation / Automation
Cybersecurity and Privacy
Early-Stage Pharma, Biotech and Medical Device companies
Commercial / Inspection Readiness